These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 37689812)

  • 1. Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) in Japan 2023.
    Matsumoto M; Miyakawa Y; Kokame K; Ueda Y; Wada H; Higasa S; Yagi H; Ogawa Y; Sakai K; Miyata T; Morishita E; Fujimura Y;
    Int J Hematol; 2023 Nov; 118(5):529-546. PubMed ID: 37689812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) 2017 in Japan.
    Matsumoto M; Fujimura Y; Wada H; Kokame K; Miyakawa Y; Ueda Y; Higasa S; Moriki T; Yagi H; Miyata T; Murata M;
    Int J Hematol; 2017 Jul; 106(1):3-15. PubMed ID: 28550351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New developments in treatment modalities of thrombotic thrombocytopenic purpura].
    Matsumoto M
    Rinsho Ketsueki; 2017; 58(10):2081-2086. PubMed ID: 28978852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frontiers in pathophysiology and management of thrombotic thrombocytopenic purpura.
    Kubo M; Matsumoto M
    Int J Hematol; 2023 Mar; 117(3):331-340. PubMed ID: 36757521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathogenesis and novel treatment of thrombotic thrombocytopenic purpura].
    Matsumoto M
    Rinsho Ketsueki; 2021; 62(5):480-485. PubMed ID: 34248125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 as a Potential Trigger for Immune Thrombotic Thrombocytopenic Purpura and Reason for an Unusual Treatment: A Case Report.
    Schwaegermann MK; Hobohm L; Rausch J; Reuter M; Griemert TF; Sivanathan V; Falter T; Sprinzl MF; Lackner KJ; Galle PR; Konstantinides S; Theobald M; von Auer C
    Hamostaseologie; 2023 Jun; 43(3):215-218. PubMed ID: 34327693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis and treatment of thrombotic thrombocytopenic purpura].
    Kubo M; Matsumoto M
    Rinsho Ketsueki; 2020; 61(5):529-535. PubMed ID: 32507820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Cell Directed Therapy for Immune Thrombotic Thrombocytopenic Purpura (iTTP).
    Chen M; Shortt J
    Transfus Med Rev; 2022 Oct; 36(4):204-214. PubMed ID: 36396570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The frontline of TMA management].
    Saito K; Matsumoto M
    Rinsho Ketsueki; 2022; 63(5):463-470. PubMed ID: 35662172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombotic Thrombocytopenic Purpura: Pathophysiology, Diagnosis, and Management.
    Sukumar S; Lämmle B; Cataland SR
    J Clin Med; 2021 Feb; 10(3):. PubMed ID: 33540569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Novel treatment strategies for acquired thrombotic thrombocytopenic purpura].
    Matsumoto M
    Rinsho Ketsueki; 2023; 64(9):1124-1130. PubMed ID: 37899191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thrombotic thrombocytopenic purpura - a rare diagnosis].
    Einarsdottir S; Rosander C; Frändberg S; Dezfoolian H; Lisak M
    Lakartidningen; 2023 Sep; 120():. PubMed ID: 37712566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment strategy for patients with thrombotic thrombocytopenic purpura].
    Yagi H
    Rinsho Ketsueki; 2021; 62(8):1222-1228. PubMed ID: 34497210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in thrombotic thrombocytopenic purpura.
    Sadler JE; Moake JL; Miyata T; George JN
    Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thrombotic Thrombocytopenic Purpura --Pathophysiology and Assays of ADAMTS13 Activity].
    Kato S; Fujimura Y
    Rinsho Byori; 2015 Oct; 63(10):1228-36. PubMed ID: 26897861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADAMTS13 in the New Era of TTP.
    Papakonstantinou A; Kalmoukos P; Mpalaska A; Koravou EE; Gavriilaki E
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombotic thrombocytopenic purpura.
    Joly BS; Coppo P; Veyradier A
    Blood; 2017 May; 129(21):2836-2846. PubMed ID: 28416507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caplacizumab for relapsing thrombotic thrombocytopenic purpura.
    Kaczmarek V; Holle J; Astudillo R; Kempf C; Bufler P; Müller D
    Pediatr Nephrol; 2019 Sep; 34(9):1625-1628. PubMed ID: 31177334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Von Willebrand factor assays in patients with acquired immune thrombotic thrombocytopenia purpura treated with caplacizumab.
    Bowyer A; Brown P; Hopkins B; Scully M; Shepherd F; Lowe A; Mensah P; Maclean R; Kitchen S; van Veen JJ
    Br J Haematol; 2022 May; 197(3):349-358. PubMed ID: 35262910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Advances in the treatment of thrombotic thrombocytopenic purpura].
    Uchihara M; Kubo M; Matsumoto M
    Rinsho Ketsueki; 2024; 65(6):567-575. PubMed ID: 38960658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.